STAB1 and neoplasm: Despite the potential of M2-like macrophages to support leukemia cell growth3–6, here we focused on studying the effects of bexmarilimab on malignant myeloid cells since the anti-tumor effects of inhibiting macrophage CLEVER-1 have been extensively characterized7–9,12.